Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.

Biomark Res · 2015 · PMC4443545 · PMID 26015868

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In addition, there was a highly significant association between higher levels of genomic scars and both p53 mutation (Additional file 4 : Figure S4) and higher grade (Additional file 6 : Figure S6).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.